Evidence map›Paper›PMID 33306173›Full record

ReviewProgress in the chemistry of organic natural products2020

The Phytochemistry and Pharmacology of Hypericum.

Chuan-Yun Xiao, Qing Mu, Simon Gibbons

Abstract readReview
PubMed Publisher
In one paragraph

Review in Progress in the chemistry of organic natural products, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. New Stilbene Dimer Compounds from the Fruits ofMolecules (Basel, Switzerland) · 2026
    Article
  2. Integrated LC-HRMS and HPLC Profiling of Fourteen AnatolianPharmaceuticals (Basel, Switzerland) · 2026
    Article
  3. The Diels-Alder Reaction as a Key Step in Natural Product Synthesis.Progress in the chemistry of organic natural products · 2026
    Review
  4. Article
  5. Polyprenylated Acylphloroglucinols fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Plants (Basel, Switzerland) · 2025
    Review
  7. Chemical Composition and Biological Activity ofPlants (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Outstanding Antibacterial Activity ofLife (Basel, Switzerland) · 2023
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chuan-Yun XiaoDepartment of Natural Medicine, School of Pharmacy, Shanghai Engineering Research Center of Immuno Therapeutics, Fudan University, 826 Zhangheng Road, Zhangjiang Pudong, Shanghai, 201203, China. xiaocy1992@163.com.
Qing MuDepartment of Natural Medicine, School of Pharmacy, Shanghai Engineering Research Center of Immuno Therapeutics, Fudan University, 826 Zhangheng Road, Zhangjiang Pudong, Shanghai, 201203, China.
Simon GibbonsSchool of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypericum L. is a genus of the family Hypericaceae within the dicotyledones. The constituents of Hypericum species are valued for their important biological properties. Their use is in the treatment of depression and as antibacterial agents has been well documented in the primary literature and in ethnobotanical reports. The present contribution gives a comprehensive summary of the chemical constituents of members of the genus Hypericum and their biological effects. A detailed account of the chemical constituents, including phloroglucinol derivatives, xanthones, dianthrones, and flavonoids, is included. These compounds show a diverse range of biological activities that include antimicrobial, cytotoxic, antidepressant-like, and antinociceptive effects.

Indexed as

HypericumPlant ExtractsAntidepressive AgentsAnti-Infective AgentsAntidepressive AgentsAnti-Infective AgentsPlant ExtractsBiological activitiesChemical constituentsHypericum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.